Navigation Links
James P. Abely Joins Psychemedics Corporation as Associate General Counsel
Date:6/22/2016

ACTON, Mass., June 22, 2016 /PRNewswire/ -- Psychemedics Corporation (NASDAQ: PMD) announced that James P. Abely has joined the company as Associate General Counsel.

In this important role, Jim will be responsible for directing and managing all of the company's legal activities, including working closely with the company's clients.  He will report to the company's CEO.  Jim practiced law with the Boston firm of Goodwin Procter LLP following his graduation from the University of Virginia School of Law. His strong litigation background will be most helpful to Psychemedics and its clients.

Raymond C. Kubacki, Chairman and CEO of Psychemedics, stated, "We are extremely pleased to have Jim joining our team and heading up this important area in our company. Besides providing our clients with the most vigorous drug test available and outstanding client service, we also directly support our clients on any legal challenge.  We not only provide a litigation packet and expert testimony, but also legal assistance for our client's legal team to come up to speed quickly.  That's why this is such an important role in our company and beyond the normal role of Associate General Counsel."

Psychemedics Corporation is the world's largest provider of hair testing for the detection of drugs of abuse. The Company's patented process is used by thousands of U.S. and international clients, including over 10% of the Fortune 500 companies, for pre-employment and random drug testing. Major police departments, Federal Reserve Banks, schools, and other public entities also rely on our unique patented drug testing process. We strongly believe our drug testing method to be superior to any other product currently in use, including traditional urine testing and other hair testing methods.

The Psychemedics web site is www.psychemedics.com

Cautionary Statement for purposes of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995:  From time to time, information provided by Psychemedics may contain forward-looking information that involves risks and uncertainties.  In particular, statements contained in this release that are not historical facts (including but not limited to statements concerning earnings, earnings per share, revenues, cash flows, dividends, future business, growth opportunities (including an opportunity in Brazil), new accounts, customer base, market share, test volume, sales and marketing strategies, U.S. and foreign drug testing laws and regulations including effective dates thereof, required investments in plant, equipment and people and new test development) may be "forward looking" statements.  Actual results may differ from those stated in any forward-looking statements.  Factors that may cause such differences include but are not limited to risks associated with the development of markets for new products and services offered, costs of capacity expansion, U.S. and foreign government regulation, including but not limited to FDA regulations, Brazilian laws and regulations and projected implementation dates, proposed laws and regulations, R&D spending, competition (including, without limitation, competition from other companies pursuing the same growth opportunities) and general economic conditions and other factors disclosed in the Company's filings with the Securities and Exchange Commission. Information regarding testing volume for a partial quarter may not necessarily be an indicative of results to be expected for the full quarter or year. The forward-looking statements contained herein speak only of the Company's expecta­tions as of the date of this press release. The Company express­ly disclaims any obligation or undertaking to release publicly any updates or revi­sions to any such statement to reflect any change in the Company's expectations or any change in events, conditions, or circumstances on which any such statement is based. 

Contact:
Raymond C. Kubacki
Chairman, President and CEO 
(978) 206-8220

Logo - http://photos.prnewswire.com/prnh/20111107/NE00639LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/james-p-abely-joins-psychemedics-corporation-as-associate-general-counsel-300288685.html


'/>"/>
SOURCE Psychemedics Corporation
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. FinancialBuzz.com Exclusive NASDAQ MarketSite Interview with Aethlon Medical, Inc. CEO James Joyce
2. Estetique Ramps Up Growth; Appoints James Walker to Board of Directors
3. Mylan to Present at the Raymond James 37th Annual Institutional Investors Conference
4. Haemonetics to Present at the Raymond James 37th Annual Institutional Investors Conference
5. HeartWare Presentation At The Raymond James 37th Annual Institutional Investors Conference To Be Webcast
6. Diplomat to Participate in the Raymond James & Associates 37th Annual Institutional Investors Conference
7. Astellas Names James Robinson President, Americas Operations
8. Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer
9. Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern
10. Pharmaceutical Industry Leader James Dolan Joins Relmada Therapeutics Advisory Team
11. Relmada Therapeutics Files Federal Lawsuit Against Laidlaw & Company and its Principals Matthew Eitner and James Ahern to Protect Interests of Relmada Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/12/2017)... SAN FRANCISCO , Sept. 12, 2017 /PRNewswire/ ... Lifecycle Management Solutions (VLMS), is pleased to announce ... as a member of its Board of Directors ... 2017. ValGenesis VLMS enables life science companies to ... eliminate the use of paper in this process. ...
(Date:9/9/2017)... 8, 2017 Dealmed Medical Supplies, ... medical equipment, supplies, drugs, vaccines, and specialty medical products ... an agreement to acquire Vantage Medical Supplies, a major ... Holtsville, New York . ... and emerging medical practices, will operate under the Dealmed ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work ... as “patient engagement.” The patient is doing more than filling out a survey; in ... “There is an increasing emphasis in health care and research on the importance of ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate ... primary prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
Breaking Medicine News(10 mins):